Off-Label Use Beyond GLP-1

GLP-1 medications being used off-label for weight loss, and the corresponding audit risk, has been a hot topic for awhile now, but there are other medications that PAAS National® frequently sees recoupments for when being used off-label, especially when billed to a Medicare plan.

Other medications recently recouped by Medicare Part D Plan Sponsors and PBMs include:

Become an audit assistance member today to continue reading this article. As a member, you’ll have access to hundreds of articles and receive our monthly proactive newsletter!

  • Diclofenac 3% indicated for actinic keratosis but being used for pain
  • Pennsaid® solution 2% indicated for the treatment of osteoarthritis of the knee but being used on other body parts
  • Prenatal vitamins prescribed for non-child bearing aged women
  • Alcohol swabs not being used for insulin administration
  • Compounds using bulk pharmaceutical powders, off-label, or unapproved uses
  • Ivermectin being used for COVID-19

PBMs seem to selectively enforce these provisions, but the reality is they are pursuing easy targets with high rewards. Audits typically identify claim outliers, and expensive medications with narrow therapeutic indications increase the likelihood of an audit. Prescriptions being used within FDA guidelines are much less likely to be identified as being used off-label.

Section 1860D-2(e)(4) of the Social Security Act defines medically accepted indications for the Medicare Part D program by referencing Section 1927(k)(6). It states that a medically accepted indication is “any use for a covered outpatient drug which is approved under the Federal Food, Drug, and Cosmetic Act, or the use of which is supported by one or more citations include or approved for inclusion in any compendia described in Section 1927(g)(1)(B)(i)”.

When recoupments from off-label uses happen, they can be difficult to appeal. Remember to send PAAS your audit notices as soon as you receive them to have the best chance at success.

PAAS Tips:

Jenevra Azzopardi, CPhT